TGFβ-15 Peptide Vaccine (Herlev Hospital)

N/A

Report date: 2024/07/03 21:31:43

Base Information

Drug NameTGFβ-15 Peptide Vaccine (Herlev Hospital)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHerlev Hospital
China Registration ClassN/A

Develop Information

Active CompaniesHerlev Hospital
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A